Skip to main content
main-content
Top

06-01-2018 | Obesity | Article

Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study

Journal: Nutrition & Diabetes

Authors: Ebenezer S. Adjah Owusu, Mayukh Samanta, Jonathan E. Shaw, Azeem Majeed, Kamlesh Khunti, Sanjoy K. Paul

Publisher: Nature Publishing Group UK

share
SHARE

Abstract

Background

Undiagnosed comorbid diseases that independently lead to weight loss before type 2 diabetes mellitus (T2DM) diagnosis could explain the observed increased mortality risk in T2DM patients with normal weight.

Objectives

To evaluate the impact of weight change patterns before the diagnosis of T2DM on the association between body mass index (BMI) at diagnosis and mortality risk.

Methods

This was a longitudinal cohort study using 145,058 patients from UK primary care, with newly diagnosed T2DM from January 2000. Patients aged 18–70, without established disease history at diagnosis (defined as the presence of cardiovascular diseases, cancer, and renal diseases on or before diagnosis) were followed up to 2014. Longitudinal 6-monthly measures of bodyweight three years before (used to define groups of patients who lost bodyweight or not before diagnosis) and 2 years after diagnosis were obtained. The main outcome was all-cause mortality.

Results

At diagnosis, mean (SD) age was 52 (12) years, 56% were male, 52% were current or ex-smokers, mean BMI was 33 kg/m2, and 66% were obese. Normal weight and overweight patients experienced a small but significant reduction in body weight 6 months before diagnosis. Among all categories of obese patients, consistently increasing body weight was observed within the same time window.
Among patients who did not lose body weight pre-diagnosis (n = 117,469), compared with the grade 1 obese, normal weight patients had 35% (95% CI of HR: 1.17, 1.55) significantly higher adjusted mortality risk. However, among patients experiencing weight loss before diagnosis (n = 27,589), BMI at diagnosis was not associated with mortality risk (all p > 0.05).

Conclusions

Weight loss before the diagnosis of T2DM was not associated with the observed increased mortality risk in normal weight patients with T2DM. This emphasises the importance of addressing risk factors post diagnosis for excess mortality in this group.
Literature
1.
Carnethon, M. R. et al. Association of weight status with mortality in adults with incident diabetes. JAMA 308, 581–590 (2012). PubMedPubMedCentral
2.
Kokkinos, P. et al. BMI–mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care 35, 1021–1027 (2012). CrossRefPubMedPubMedCentral
3.
Logue, J. et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36, 887–893 (2013). CrossRefPubMedPubMedCentral
4.
Mulnier, H. E. et al. Mortality in people with type 2 diabetes in the UK. Diabet. Med.: J. Br. Diabet. Assoc. 23, 516–521 (2006). CrossRef
5.
Thomas, G. et al. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes. Metab. 16, 317–325 (2014). CrossRefPubMed
6.
Weiss, A., Boaz, M., Beloosesky, Y., Kornowski, R. & Grossman, E. Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet. Med.: J. Br. Diabet. Assoc. 26, 253–259 (2009). CrossRef
7.
Zoppini, G. et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int. J. Obes. 27, 281–285 (2003). CrossRef
8.
Zhao W., et al. Body mass index and the risk of all-cause mortality among patients with Type 2 diabetes. Circulation. 130, 2143–2151 (2014). Published online before print.
9.
Costanzo, P. et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann. Intern. Med. 162, 610–618 (2015). CrossRefPubMed
10.
Tobias, D. K. et al. Body-mass index and mortality among adults with incident type 2 diabetes. New Engl. J. Med. 370, 233–244 (2014). CrossRefPubMedPubMedCentral
11.
Goyal, A., Nimmakayala, K. R. & Zonszein, J. Is there a paradox in obesity? Cardiol. Rev. 22, 163–170 (2014). CrossRefPubMedPubMedCentral
12.
de Fine Olivarius, N., Siersma, V. D., Koster-Rasmussen, R., Heitmann, B. L. & Waldorff, F. B. Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. Results from the Danish Diabetes Care in General Practice (DCGP) study. PloS ONE 10, e0122219 (2015). CrossRefPubMedPubMedCentral
13.
Heianza, Y. et al. Trajectory of body mass index before the development of type 2 diabetes in Japanese men: Toranomon Hospital Health Management Center Study 15. J. Diabetes Investig. 6, 289–294 (2015). CrossRefPubMedPubMedCentral
14.
Looker, H. C., Knowler, W. C. & Hanson, R. L. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24, 1917–1922 (2001). CrossRefPubMed
15.
Vistisen, D. et al. Patterns of obesity development before the diagnosis of type 2 diabetes: The Whitehall II Cohort Study. PLOS Med. 11, e1001602 (2014). CrossRefPubMedPubMedCentral
16.
Wannamethee, S. G. & Shaper, A. G. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22, 1266–1272 (1999). CrossRefPubMed
17.
IMS Health Incorporated. The Health Improvement Network (THIN) database London: IMS Health Incorporated. http://​www.​csdmruk.​imshealth.​com/​index.​html (2017).
18.
THIN Database Research Team. THIN database London: UCL. https://​www.​ucl.​ac.​uk/​pcph/​research-groups-themes/​thin-pub (2017).
19.
Blak, B. T., Thompson, M., Dattani, H. & Bourke, A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform. Prim. Care 19, 251–255 (2011). PubMed
20.
Denburg, M. R., Haynes, K., Shults, J., Lewis, J. D. & Leonard, M. B. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol. Drug Saf. 20, 1138–1149 (2011). CrossRefPubMedPubMedCentral
21.
Read, J. The Read clinical classification (Read codes). Br. Homoeopath. J. 80, 14–20 (1991). CrossRef
22.
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L. & Hall, A. J. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br. J. Clin. Pharmacol. 69, 4–14 (2010). CrossRefPubMedPubMedCentral
23.
Khan, N. F., Harrison, S. E. & Rose, P. W. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br. J. Gen. Pract. 60, e128–e136 (2010). CrossRefPubMedPubMedCentral
24.
Owusu Adjah E. S., Montvida O., Agbeve J., Paul S. K. Data mining approach to identify disease cohorts from primary care electronic medical records: a case of diabetes mellitus. Open Bioinform. J. 10, 16–27 (2017). CrossRef
25.
Townsend P., Phillimore P., Beattie A. Health and deprivation: inequality and the north (Croom Helm, London, 1988).
26.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157 (2004). CrossRef
27.
Aucott, L. S. et al. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open 6, e010836 (2016). CrossRefPubMedPubMedCentral
28.
Pi-Sunyer, F. X. Weight loss in type 2 diabetic patients. Diabetes Care 28, 1526–1527 (2005). CrossRefPubMed
29.
Carnethon, M. R., Rasmussen-Torvik, L. J. & Palaniappan, L. The obesity paradox in diabetes. Curr. Cardiol. Rep. 16, 446 (2014). CrossRefPubMed
30.
Khalangot, M., Tronko, M., Kravchenko, V., Kulchinska, J. & Hu, G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: A large prospective study in Ukraine. Heart (Br. Card. Soc.). 95, 454–460 (2009). CrossRef
31.
Banack, H. R. & Kaufman, J. S. The “Obesity Paradox” explained. Epidemiol. (Camb., Mass). 24, 461–462 (2013). CrossRef
32.
Banack, H. R. & Kaufman, J. S. Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann. Epidemiol. 25, 342–349 (2015). CrossRefPubMed
33.
Hainer, V. & Aldhoon-Hainerová, I. Obesity paradox does exist. Diabetes Care 36(Supplement 2), S276–S281 (2013). CrossRefPubMedPubMedCentral
34.
Batterham, M., Tapsell, L. C. & Charlton, K. E. Baseline characteristics associated with different BMI trajectories in weight loss trials: a case for better targeting of interventions. Eur. J. Clin. Nutr. 70, 207–211 (2016). CrossRefPubMed
35.
de Lusignan, S. et al. An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR). J. Innov. Health Inform. 22, 255–264 (2015). CrossRefPubMed
36.
de Lusignan, S. et al. Call for consistent coding in diabetes mellitus using the Royal College of General Practitioners and NHS pragmatic classification of diabetes. Inform. Prim. Care. 20, 103–113 (2012). PubMed
37.
Hassan Sadek, N. et al. Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control. Int. J. Clin. Pract. 66, 874–882 (2012). CrossRefPubMedPubMedCentral
38.
Sadek, A. R., van Vlymen, J., Khunti, K. & de Lusignan, S. Automated identification of miscoded and misclassified cases of diabetes from computer records. Diabet. Med.: a J. Br. Diabet. Assoc. 29, 410–414 (2012). CrossRef

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

The challenge of type 2 diabetes in children

Who is at the highest risk for developing type 2 diabetes in their youth? 

Supporting people with diabetes during Ramadan

Evidence overview and practical advice for fasting with type 1 or type 2 diabetes